Skip Navigation

European Heart Journal 2003 24(6):490-493; doi:10.1016/S0195-668X(02)00697-8
Copyright © 2003 by the European Society of Cardiology.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Thambyrajah, J
Right arrow Articles by De Belder, M.A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thambyrajah, J
Right arrow Articles by De Belder, M.A
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorial

Management of non ST-segment elevation acute coronary syndromes—continuing the search for the bad guys

J Thambyrajah and M.A De Belder*

Cardiothoracic Division, The James Cook University Hospital, Marton Road, TS4 3BW Middlesbrough, UK

* Corresponding author. Tel.: +44-1642-854620; fax: +44-1642-282408

The first 150 words of the full text of this article appear below.

See doi:10.1016/S1095-668X(02)00525-0for the article to which this editorial refers.

Patients with non ST-segment elevation (STE) acute coronary syndromes (ACS) are subject to a significant risk of adverse cardiac events. The recognition that up to 50% of these patients will experience recurrent ischaemia and 10% will die or reinfarct within 30 days despite optimum medical management has prompted investigation into better pharmacological therapy and the role of invasive procedures.1–3 However, the timing of intervention is controversial and two different protocols, an ‘early invasive strategy’ and an ‘early conservative strategy’, have been assessed.

The first randomized trials either failed to show an advantage with early intervention (TIMI IIIB)3 or suggested that this approach could potentially be harmful (VANQWISH) compared to an early conservative strategy.4 In the OASIS registry, a large multicentre prospective observational study of an unselected population with non-STE ACS, admission to centres with cardiac catheterization theatres increased the likelihood of . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Does the discharge ECG provide additional prognostic insight(s) in non-ST elevation ACS patients from that acquired on admission?
A. Hersi, Y. Fu, B. Wong, K.W. Mahaffey, R.A. Harrington, R.M. Califf, F. Van de Werf, P.W. Armstrong, and for the PARAGON-B Investigators
EHJ 2003 24: 522-531. [Abstract] [Full Text]  



This article has been cited by other articles:


Home page
 Eur Heart J SupplHome page
A. Elsasser and C. W. Hamm
Percutaneous coronary intervention guidelines: new aspects for the interventional treatment of acute coronary syndromes
Eur. Heart J. Suppl., October 1, 2005; 7(suppl_K): K5 - K9.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
Authors/Task Force Members, S. Silber, P. Albertsson, F. F. Aviles, P. G. Camici, A. Colombo, C. Hamm, E. Jorgensen, J. Marco, J.-E. Nordrehaug, et al.
Guidelines for Percutaneous Coronary Interventions: The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology
Eur. Heart J., April 2, 2005; 26(8): 804 - 847.
[Full Text] [PDF]